Results 61 to 70 of about 5,385 (167)
Background Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal metastasis.
N. Laplace +9 more
doaj +1 more source
Standard hematological analyses HIPEC v1 [PDF]
Standard hematological analyses EDTA-anticoagulated blood was used for cytometric analysis using a whole blood counter Sysmex XE 2100® (Sysmex,Kobe, Japan) to obtain a whole blood count. Fibrinogen levels were determined with an ACL-9000 (Diamond Diagnostics, Holliston, MA) coagulation analyser, using a PT-fibrinogen high sensitivity reagent, which ...
Sven Van Poucke +9 more
openaire +1 more source
Multidisciplinary strategies have transformed the management of advanced ovarian cancer. We aimed to evaluate the effectiveness of paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical cytoreduction for ovarian peritoneal ...
Pedro Villarejo Campos +8 more
doaj +1 more source
Background and Objectives Postoperative thromboembolism is a significant cause of prolonged recovery in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mari Tuovila +6 more
doaj +1 more source
Yuxin Zhong,1 Jing Zhang,2 Xiaofeng Bai,1 Yuemin Sun,1 Hao Liu,1 Shuai Ma,1 Yang Li,1 Wenzhe Kang,1 Fuhai Ma,1 Weikun Li,1 Yantao Tian1 1Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer ...
Zhong Y +10 more
doaj
Annals of Gastroenterological Surgery, Volume 9, Issue 5, Page 880-882, September 2025.
Hideaki Yano +9 more
wiley +1 more source
Background To explore the application value of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei (PMP). Methods We retrospectively analyzed the clinical data of 526 patients
Bing Wang +5 more
doaj +1 more source
Cytoreductuctive surgery and HIPEC
Systemic treatment alone is no longer appropriate for patients with limited peritoneal dissemination from primary or recurrent colon cancer. A clinical pathway for the management of these patients should include cytoreductive surgery and HIPEC. There are four specific problems that have to be resolved in the future in order to improve survival of the ...
Kekez, Tihomir +10 more
openaire +3 more sources
Background. The high prevalence of advanced forms of cancer currently requires new treatment approaches. Only modern high-tech surgical procedures can provide means for improving the results of treatment.The aim.
S. I. Radostev +5 more
doaj +1 more source
An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy
Background: Complete cytoreduction is acknowledged to be an effective way to achieve macroscopic tumor clearance for a variety of tumors confined to the peritoneal cavity.
Frédéric Mercier +7 more
doaj +1 more source

